IRF4 and Miyoshi myopathy: Interestingly, miR-125b has been recently found to induce direct anti-MM activity both in vitro and in vivo by effectively targeting IRF4, an important molecular involved in the development and differentiation of Treg, Th2, Th9, and Th17 cells [36].